Mutations in progranulin gene (GRN), a known risk factor for familiar FTD, have been shown to modulate microglial activation and the production of pro-inflammatory cytokines, amplifying neuroinflammatory responses [30,50]. This evidence concerns the gene GRN and frontotemporal dementia.